1. Long noncoding RNA linc00467 plays an oncogenic role in hepatocellular carcinoma by regulating the miR‐18a‐5p/NEDD9 axis
   Yuanwen Zheng et al, 2020, Journal of Cellular Biochemistry CrossRef
2. Targeting Non-Coding RNAs for the Development of Novel Hepatocellular Carcinoma Therapeutic Approaches
   Tanja Jesenko et al, 2023, Pharmaceutics CrossRef
3. Integrated multi-omics analysis identifies ENY2 as a predictor of recurrence and a regulator of telomere maintenance in hepatocellular carcinoma
   Jian-Hua Li et al, 2022, Frontiers in Oncology CrossRef
4. Oncogenic driver genes and the inflammatory microenvironment dictate liver tumor phenotype
   Matthias S. Matter et al, 2016, Hepatology CrossRef
5. NEDD9 may regulate hepatocellular carcinoma cell metastasis by promoting epithelial-mesenchymal-transition and stemness via repressing Smad7
   Zhipeng Wang et al, 2017, Oncotarget CrossRef
6. Potential utility of l-carnitine for preventing liver tumors derived from metabolic dysfunction–associated steatohepatitis
   Junyan Lyu et al, 2024, Hepatology Communications CrossRef
7. Serum neural precursor cell-expressed, developmentally down regulated 9 (NEDD9) level may have a prognostic role in patients with gastric cancer
   Mehmet Karabulut et al, 2015, Biomedicine & Pharmacotherapy CrossRef
8. High MRPS23 expression contributes to hepatocellular carcinoma proliferation and indicates poor survival outcomes
   Meng Pu et al, 2017, Tumor Biology CrossRef
9. Significance of serum neural precursor cell‑expressed developmentally downregulated protein 9 in melanoma
   Kayhan Erturk et al, 2017, Molecular and Clinical Oncology CrossRef
10. Overexpression of NEDD9 promotes cell invasion and metastasis in hepatocellular carcinoma
    Senjun Zhou et al, 2017, Clinics and Research in Hepatology and Gastroenterology CrossRef
11. Progesterone and calcitriol reduce invasive potential of endometrial cancer cells by targeting ARF6, NEDD9 and MT1-MMP
    Sana Waheed et al, 2017, Oncotarget CrossRef